Prognosis of occupational asthma

Annals of Allergy, Asthma and Immunology

Volumn 83, Issue 6 II, 1999, Pages 593-596

  Montanaro, Anthony ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST; HUMAN; MORBIDITY; OCCUPATIONAL ASTHMA; OCCUPATIONAL HAZARD; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

EID: 0033386445     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1081-1206(10)62878-5     Document Type: Review

References (23)

1. Malo Jean-Luc, Chan-Yeung MM. Occupational agents. Asthma 1994;85: 1217-1229.
2. Venables KM, Chan-Yeung M. Occupational asthma. Lancet 1997;349: 1456-1469.
3. Young MA, Reynolds JC. Respiratory complications of gastrointestinal diseases. Gastroenterol Clin North Am 1998;27(4):721-746.
4. Newman KB, Dubester SN. Vocal cord dysfunction: masquerader of asthma. Semin Respir Crit Care Med 1994;15:161-167.
5. Patterson DL, O'Connell EJ. Vocal cord dysfunction: what have we learned in 150 years? Insights Allergy 1994;9:1-12.
6. Martin RJ, Blager FB, Gay ML, Wood RP. Paradoxic vocal cord motion in presumed asthmatics. Semin Respir Med 1987;8:332-337.
7. Timmerman S, Rosenman K. Occurrence of occupational asthma. 1993; 104:816.
8. Wheeler S, Rosenstock L, Barnhart S. A case series of 71 patients referred to a hospital-based occupational and environmental medicine clinic for occupational asthma. WPM 1998;168: 98-104.
9. Montanaro M. Isocyanate asthma. In: Bardana E, Montanaro A, O'Holloren M, eds. Occupational Asthma. 1991: 131-143.
10. Fabbri LM, Mapp CE, Boschetto P, et al. Occupational asthma due to isocyanates. Eur Respir J 1988;1:273-279.
11. Banks DE, Butcher BT, Salvaggio JE. Isocyanate-induced respiratory disease. Ann Allergy 1986;57:389.
12. Tarlo SM, Liss GM, Dias C, Banks DE. Assessment of the relationship between isocyanate exposure levels and occupational asthma. Am J Ind Med 1997;32(5):517-521.
13. Wegman DH, Peters JM, Pagnotto LD, Fine LC. Chronic pulmonary function loss from exposure to toluene diisocyanate. Br J Ind Med 1977;34: 196-200.
14. Adams WGF. Long-term effects on the health of men engaged in the manufacture of toluene diisocyanate. Br J Ind Med 1975;32:72-78.
15. Diem JB, Jones RN, Hendrick DS, et al. Five-year longitudinal study of workers employed in a new toluene diisocyanate manufacturing plant. Am Rev Respir Dis 1982;126:420-426.
16. Moller DR, Brooks SM, McKay RT, et al. Chronic asthma due to toluene diisocyanate. Chest 1986;90:494-499.
17. Saetta M, Maestrelli P, Turato G, et al. Airway wall remodeling after cessation of exposure to isocyanates in sensitized asthmatic subjects. Am J Respir Crit Care Med 1995;151:489-494.
18. Tarlo SM, Sussman G, Contala A, et al. Control of airborne latex by use of powder-free latex gloves. J Allergy Clin Immunol 1994;93:985-989.
19. Chan-Yeung M, MacLean L, Paggiaro PL. Follow-up study of 232 patients with occupational asthma caused by western red cedar (Thuja plicata). J Allergy Clin Immunol 1987;79: 792-796.
20. Montanaro A. Chemically induced nonspecific bronchial hyperresponsiveness. Clin Rev Allergy Immunol 1997;15:187-203.
21. Malo JL. Irritant-induced asthma and reactive airways dysfunction syndrome. Can Respir J 1998;5:66-67.
22. Lemiere C, Malo JL, Boutet M. Reactive airways dysfunction syndrome due to chlorine: Sequential bronchial biopsies and functional assessment. Eur Respir J 1997;10:241-244.
23. Malo J-L, Cartier A, Boulet LP, et al. Bronchial hyperresponsiveness can improve while spirometry plateaus 2 to 3 years after repeated exposure to chlorine causing respiratory symptoms. Am J Respir Crit Care Med 1994;150: 1142-1145.